{
    "title": "AstraZeneca gives investors a boost",
    "url": "https://www.dailymail.co.uk/money/markets/article-1700261/AstraZeneca-gives-investors-a-boost.html",
    "date": "2010-07-30",
    "keywords": [
        "seroquel",
        "growth",
        "year",
        "crestor",
        "astrazeneca",
        "drug",
        "profit",
        "pill",
        "giant",
        "quarter",
        "group",
        "competition",
        "company",
        "performance",
        "patent",
        "treatment",
        "nexium",
        "boost",
        "money",
        "gmt",
        "july",
        "view",
        "value",
        "share",
        "buyback",
        "scheme",
        "depressionbuster",
        "measure",
        "market",
        "business",
        "boss",
        "david",
        "brennan",
        "symbicort",
        "half",
        "astra",
        "vaccine",
        "pressure",
        "arimidex",
        "breast",
        "cancer",
        "month",
        "companys",
        "secondquarter",
        "increase",
        "gain",
        "symbiocort",
        "asthma",
        "rise",
        "medicine",
        "period",
        "court",
        "victory",
        "ulcer",
        "deal",
        "europe",
        "loss",
        "need",
        "replacement",
        "line",
        "panel",
        "food",
        "administration",
        "fda",
        "sale",
        "brilinta",
        "blood",
        "thinner",
        "risk",
        "heart",
        "foregone",
        "conclusion",
        "advice",
        "committee",
        "slew",
        "industry"
    ],
    "category": [
        "money",
        "markets"
    ]
}